本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagonist Therapeutics Inc

105.44
+0.72000.69%
盘后105.440.00000.00%16:52 EDT
成交量:77.02万
成交额:8,053.88万
市值:67.28亿
市盈率:-51.43
高:106.66
开:105.96
低:103.02
收:104.72
52周最高:107.84
52周最低:41.29
股本:6,380.87万
流通股本:4,315.48万
量比:0.95
换手率:1.78%
股息:- -
股息率:- -
每股收益(TTM):-2.0500
每股收益(LYR):-2.0500
净资产收益率:-20.18%
总资产收益率:-13.99%
市净率:10.95
市盈率(LYR):-51.43

数据加载中...

2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/16

重要事件披露

Form 8-K - Current report